Mitsubishi UFJ Asset Management
CRL icon

Mitsubishi UFJ Asset Management’s Charles River Laboratories CRL Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
66,864
+3,104
+5% +$553K 0.01% 571
2026
Q1 		$11M Buy
63,760
+5,363
+9% +$994K 0.01% 591
2025
Q4 		$11.8M Buy
58,397
+2,391
+4% +$434K 0.01% 585
2025
Q3 		$8.76M Buy
56,006
+63
+0.1% +$10K 0.01% 603
2025
Q2 		$8.49M Buy
55,943
+1,486
+3% +$198K 0.01% 605
2025
Q1 		$8.2M Sell
54,457
-26,287
-33% -$4.41M 0.01% 597
2024
Q4 		$15M Buy
80,744
+364
+0.5% +$70.1K 0.01% 532
2024
Q3 		$15.8M Buy
80,380
+12,433
+18% +$2.58M 0.02% 508
2024
Q2 		$14M Buy
67,947
+4,830
+8% +$1.09M 0.02% 506
2024
Q1 		$17.1M Buy
63,117
+13,691
+28% +$3.27M 0.02% 470
2023
Q4 		$11.1M Sell
49,426
-72
-0.1% -$14.2K 0.02% 499
2023
Q3 		$9.7M Buy
49,498
+2,065
+4% +$424K 0.02% 493
2023
Q2 		$9.97M Buy
47,433
+7,041
+17% +$1.4M 0.02% 493
2023
Q1 		$8.15M Buy
40,392
+3,051
+8% +$691K 0.02% 507
2022
Q4 		$8.16M Buy
37,341
+1,788
+5% +$390K 0.02% 485
2022
Q3 		$7M Buy
35,553
+4,310
+14% +$930K 0.02% 484
2022
Q2 		$6.68M Buy
31,243
+3,151
+11% +$770K 0.03% 494
2022
Q1 		$7.98M Buy
28,092
+2,197
+8% +$677K 0.03% 482
2021
Q4 		$9.38M Buy
25,895
+3,289
+15% +$1.28M 0.04% 453
2021
Q3 		$9.33M Buy
22,606
+2,116
+10% +$879K 0.05% 412
2021
Q2 		$7.58M Buy
20,490
+18,069
+746% +$6.03M 0.04% 455
2021
Q1 		$702K Buy
2,421
+921
+61% +$256K ﹤0.01% 839
2020
Q4 		$375K Sell
1,500
-137
-8% -$32.6K ﹤0.01% 864
2020
Q3 		$371K Sell
1,637
-253
-13% -$52.5K ﹤0.01% 812
2020
Q2 		$330K Sell
1,890
-592
-24% -$94.5K ﹤0.01% 819
2020
Q1 		$313K Buy
2,482
+513
+26% +$76.9K ﹤0.01% 792
2019
Q4 		$301K Buy
1,969
+5
+0.3% +$692 ﹤0.01% 827
2019
Q3 		$260K Buy
1,964
+210
+12% +$28.2K ﹤0.01% 805
2019
Q2 		$249K Sell
1,754
-128
-7% -$17.4K ﹤0.01% 807
2019
Q1 		$273K Buy
1,882
+170
+10% +$22.3K 0.01% 765
2018
Q4 		$179K Sell
1,712
-195
-10% -$24.4K ﹤0.01% 763
2018
Q3 		$257K Buy
+1,907
New +$235K 0.01% 748

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Mitsubishi UFJ Asset Management's CRL Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Charles River Laboratories (CRL) stake by 4.9% in Q2 2026, buying an estimated $553K and bringing the position to 66,864 shares worth $15.2M. The position accounts for 0.01% of the portfolio, ranked #571.

Mitsubishi UFJ Asset Management first reported a position in CRL in Q3 2018 and has held it in 32 quarters since. The position peaked at $17.1M in Q1 2024. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 66,864 shares of Charles River Laboratories worth $15.2M as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 3,104 Charles River Laboratories shares in Q2 2026, an estimated $553K.
  • Charles River Laboratories made up 0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #571 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Charles River Laboratories in Q3 2018 and has held it in 32 quarters since.
  • Mitsubishi UFJ Asset Management's Charles River Laboratories position peaked at $17.1M in Q1 2024.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.